Announcement

Collapse
No announcement yet.

Int J Antimicrob Agents. Drug repositioning an alternative for the treatment of coronavirus COVID-19

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Int J Antimicrob Agents. Drug repositioning an alternative for the treatment of coronavirus COVID-19


    Int J Antimicrob Agents. 2020 Apr 9:105969. doi: 10.1016/j.ijantimicag.2020.105969. [Epub ahead of print]
    Drug repositioning an alternative for the treatment of coronavirus COVID-19.


    Serafin MB1, Bottega A1, Foletto VS1, da Rosa TF1, H?rner A2, H?rner R3.

    Author information




    Abstract

    Given the extreme importance of the current pandemic caused by COVID-19, and due to the fact that scientists agree that there is no identified pharmacological treatment where possible therapeutic alternatives are raised through drug repositioning. We present a selection of studies involving drugs from different pharmaceutical classes with activity against SARS-CoV-2 and SARS-Cov, with potential use in the treatment of COVID-19 disease.
    Copyright ? 2020 Elsevier Ltd. All rights reserved.



    KEYWORDS:

    COVID-19; Repositioning; SARS-CoV-2


    PMID:32278811DOI:10.1016/j.ijantimicag.2020.105969


Working...
X